Ciltacabtagene autoleucel

Ciltacabtagene autoleucel, or cilta-cel, is a specialized treatment for multiple myeloma that uses your own cells. Your T cells, which are part of your immune system, are collected from your blood and then changed in a lab to specifically recognize and attach to certain markers on myeloma cells. These prepared cells are then given back to you through an IV infusion, typically in one session. This treatment helps your own cells identify and address the myeloma cells in your body. Here, you'll find clear information about the cilta-cel process, what to expect during treatment, and how it may affect your health and daily life.